Advanced company searchLink opens in new window

SWANBIO THERAPEUTICS LIMITED

Company number 10942620

Filter by category

Filter by category


Confirmation statement filters

Company Results (links open in a new window)
Date (document was filed at Companies House) Type Description (of the document filed at Companies House) View / Download (PDF file, link opens in new window)
11 Feb 2019 AD01 Registered office address changed from PO Box WC1B 3SR 8 Bloomsbury Street 8 Bloomsbury Street 2nd Floor London WC1B 3SR United Kingdom to 8 Bloomsbury Street Bloomsbury Street London WC1B 3SR on 11 February 2019
17 Dec 2018 AD01 Registered office address changed from 215 Euston Road London NW1 2BE United Kingdom to PO Box WC1B 3SR 8 Bloomsbury Street 8 Bloomsbury Street 2nd Floor London WC1B 3SR on 17 December 2018
13 Sep 2018 CS01 Confirmation statement made on 31 August 2018 with updates
21 Feb 2018 RESOLUTIONS Resolutions
  • RES01 ‐ Resolution of adoption of Articles of Association
08 Feb 2018 AP01 Appointment of Mr Julius John Sheldon Knowles as a director on 2 February 2018
07 Feb 2018 PSC02 Notification of Syncona Limited as a person with significant control on 2 February 2018
07 Feb 2018 PSC07 Cessation of Rachel Lynn Salzman as a person with significant control on 2 February 2018
07 Feb 2018 PSC07 Cessation of Karen Fran Kozarsky as a person with significant control on 2 February 2018
07 Feb 2018 PSC07 Cessation of Florian Sebald Eichler as a person with significant control on 2 February 2018
07 Feb 2018 AP01 Appointment of Mr Christopher John Hollowood as a director on 2 February 2018
07 Feb 2018 SH01 Statement of capital following an allotment of shares on 2 February 2018
  • GBP 105
08 Dec 2017 RESOLUTIONS Resolutions
  • RES15 ‐ Change company name resolution on 2017-12-07
07 Dec 2017 CONNOT Change of name notice
24 Oct 2017 RESOLUTIONS Resolutions
  • RES15 ‐ Change company name resolution on 2017-10-10
24 Oct 2017 CONNOT Change of name notice
01 Sep 2017 NEWINC Incorporation
  • MODEL ARTICLES ‐ Model articles adopted

Statement of capital on 2017-09-01
  • GBP 30